“Pep pills” is a slang term for amphetamine tablets, a class of powerful stimulant drugs that flood the brain with alertness-boosting chemicals. The term dates back to at least 1937, when the Journal of the American Medical Association used it in an editorial about Benzedrine Sulfate, the first commercially available amphetamine tablet. While the phrase sounds quaint today, the drugs it described were potent, widely abused, and chemically identical to stimulants still prescribed and misused in the 21st century.
What Pep Pills Actually Were
The original pep pills were tablets of amphetamine, a synthetic compound first studied clinically in 1927 as a replacement for a natural decongestant called ephedrine. In 1929, a biochemist named Gordon Alles discovered that the compound had striking effects on the nervous system, and the pharmaceutical company Smith, Kline and French (SKF) quickly saw commercial potential. They first sold amphetamine as the Benzedrine Inhaler, a simple tube containing oily amphetamine base marketed for nasal congestion. By 1937, the AMA had approved Benzedrine Sulfate tablets for advertising, and the era of the pep pill had begun.
By 1945, SKF’s civilian amphetamine tablet sales had quadrupled to $2 million. The company also launched Dexedrine, a more refined version using only the most active form of the amphetamine molecule (dextroamphetamine). In 1950 came Dexamyl, which blended dextroamphetamine with a sedative to take the jittery edge off the stimulant effect. Competitors flooded in with their own products, including methamphetamine-based pills sold under brand names like Desoxyn and Methedrine. All of these fell under the casual umbrella of “pep pills.”
How They Work in the Brain
Amphetamines produce their stimulant effect by forcing the brain to release abnormally large amounts of dopamine and norepinephrine, two chemical messengers tied to motivation, pleasure, focus, and the body’s fight-or-flight response. Normally, nerve cells release these chemicals in controlled bursts and then reabsorb them. Amphetamine disrupts this cycle at multiple points: it enters nerve endings and pushes stored dopamine and norepinephrine out into the gaps between cells, blocks the recycling process that would normally clear those chemicals away, and slows the enzymes that break them down.
The net result is a surge of stimulation. Heart rate and blood pressure rise. Fatigue vanishes. Appetite drops. Users feel energized, confident, and sharply focused. These effects made pep pills attractive to everyone from long-haul truck drivers and students cramming for exams to soldiers on extended combat missions and housewives trying to lose weight.
Why They Became So Popular
Pep pills spread because they were legal, cheap, and doctors prescribed them freely for an enormous range of complaints. Depression, fatigue, weight gain, nasal congestion, low mood after childbirth: amphetamines were offered as a solution for all of them. Dexamyl, the amphetamine-sedative blend, became the most commonly prescribed amphetamine product in the United States and was widely used in Britain under the name Drinamyl. The pills were also diverted in huge quantities to people using them without prescriptions, fueling what historians now call America’s first amphetamine epidemic, spanning roughly 1929 to 1971.
The military played a significant role in normalizing the drugs. Soldiers in World War II and later conflicts were given amphetamine tablets to stay awake during long operations, and many returned home familiar with, and sometimes dependent on, the effects.
The Crackdown
By the late 1960s, the scale of amphetamine misuse was impossible to ignore. In 1970, the U.S. government passed the Controlled Substances Act, which placed amphetamine and methamphetamine into Schedule II, the most restrictive category for drugs that still have accepted medical uses. Schedule II classification means the drugs can only be dispensed with a written prescription, refills are not allowed without a new prescription, and manufacturing quotas are federally controlled. The casual, over-the-counter availability that had defined the pep pill era was over.
Pep Pills and Today’s Stimulants
The chemistry behind pep pills never went away. Modern ADHD medications like Adderall (a blend of amphetamine salts) and Vyvanse (a prodrug that converts to dextroamphetamine in the body) are direct descendants of Benzedrine and Dexedrine. Desoxyn, one of the original methamphetamine-based pep pill brands from the mid-20th century, is still FDA-approved for ADHD and obesity, though it is rarely prescribed. The key difference is regulation: today’s stimulants are manufactured in precise doses, prescribed for specific diagnoses, and monitored far more carefully than the pep pills that were once handed out for a bad mood or a few extra pounds.
That said, misuse of prescription stimulants remains common. College students, shift workers, and others sometimes use Adderall or similar drugs recreationally or to boost productivity, echoing exactly the patterns that made pep pills a public health crisis decades earlier.
What Withdrawal Looks Like
One reason pep pills became so problematic is that stopping them after regular use triggers a withdrawal syndrome that pushes people to keep taking them. Within the first two to three days after quitting, symptoms peak: deep fatigue, depressed mood, irritability, increased appetite, vivid unpleasant dreams, and difficulty concentrating. The worst physical discomfort typically resolves within four to seven days.
After that first week, a longer recovery phase sets in. Over the next two to three weeks, mood and energy gradually return closer to normal. But for people who used stimulants heavily, a subtler phase can linger beyond the first month. This late stage involves mild cognitive sluggishness, ongoing cravings, and moderate depression and anxiety, driven by the slow repair of neural systems that were repeatedly overstimulated. This extended withdrawal timeline helps explain why so many people in the pep pill era struggled to quit, and why stimulant dependence remains a challenge in modern medicine.